Did anybody else catch the piece about the two women's efforts to get the drug C225 for their colorectal cancers? One was successful and is still with us today. If nothing else this kind of exposure should be beneficial to all companies working in this area. The featured company was IMCL and last traded at $41 in after hours on Fri., about half it's all time high. Would love to see SGEN move up to where the air is thin.